Summary of all the Indicators
Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Outlook Therapeutics’s (41O) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting Outlook Therapeutics is a Buy.
Outlook Therapeutics’s (41O) 20-Day exponential moving average is 1.27, while Outlook Therapeutics’s (41O) share price is €0.22, making it a Sell.
Outlook Therapeutics’s (41O) 50-Day exponential moving average is 1.03, while Outlook Therapeutics’s (41O) share price is €0.22, making it a Buy.
Outlook Therapeutics (41O) Pivot Points
Classic
1.16
1.18
1.21
1.23
1.27
1.29
1.32
Fibonacci
1.18
1.20
1.21
1.23
1.25
1.27
1.29
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Outlook Therapeutics (41O) Moving Averages
MA5
1.26Sell
1.25Sell
MA10
1.33Sell
1.29Sell
MA20
1.34Sell
1.27Sell
MA50
0.95Buy
1.03Buy
MA100
0.60Buy
0.84Buy
MA200
0.79Buy
0.93Buy
Outlook Therapeutics’s (41O) 10-Day exponential moving average is 1.29, while Outlook Therapeutics’s (41O) share price is €0.22, making it a Sell.
Outlook Therapeutics’s (41O) 100-Day exponential moving average is 0.84, while Outlook Therapeutics’s (41O) share price is €0.22, making it a Buy.
Outlook Therapeutics’s (41O) stock price is €0.22 and Outlook Therapeutics’s (41O) 50-day simple moving average is 0.95, creating a Buy signal.
Outlook Therapeutics’s (41O) stock price is €0.22 and Outlook Therapeutics’s (41O) 100-day simple moving average is 0.60, creating a Buy signal.
Outlook Therapeutics’s (41O) stock price is €0.22 and Outlook Therapeutics’s (41O) 200-day simple moving average is 0.79, creating a Buy signal.
Outlook Therapeutics (41O) Technical Indicators
RSI (14)
48.85
Neutral
STOCH (9,6)
21.01
Neutral
STOCHRSI (14)
21.01
Neutral
MACD (12,26)
0.07
Buy
ADX (14)
28.07
Neutral
Williams %R
-84.55
Buy
CCI (14)
-121.54
Buy
ATR (14)
0.12
-
Ultimate Oscillator
40.59
Neutral
ROC
-5.38
Sell
Outlook Therapeutics’s (41O) Relative Strength Index (RSI) is 48.85, creating a Neutral signal.
Outlook Therapeutics’s (41O) Trend Strength Indicator (ADX) is 28.07, creating a Neutral signal.
Outlook Therapeutics’s (41O) Commodity Channel Index (CCI) is -121.54, creating a Buy signal.
Outlook Therapeutics’s (41O) Price Rate of Change (ROC) is -5.38, creating a Sell signal.
FAQ
Is 41O a Buy, Hold, or Sell?
Based on 41O’s technical indicators, 41O is a Hold.
What is 41O’s RSI (14)?
41O’s RSI (14) is 48.85, which suggests 41O is a Neutral.
What is 41O’s MACD?
41O’s MACD is 0.07, which suggests 41O is a Buy.
What is 41O’s 5-day moving average?
41O’s 5-day moving average is 1.26, which suggests 41O is a Sell.
What is 41O’s 20-day moving average?
41O 20-day moving average is 1.34, which suggests 41O is a Sell.
What is 41O’s 50-day moving average?
41O’s 50-day moving average is 0.95, which suggests 41O is a Buy.
What is 41O’s 200-day moving average?
41O’s 200-day moving average is 0.79, which suggests 41O is a Buy.
What is 41O’s Williams % R (14)?
41O’s Williams % R (14) is -84.55, which suggests 41O is a Buy.
What is 41O’s CCI (14)?
41O’s CCI (14) is -121.54, which suggests 41O is a Buy.
What is the share price of Outlook Therapeutics?
Outlook Therapeutics's share price is N/A€.